The global intraoperative neuromonitoring (IONM) market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.88% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 3.8 Billion |
Market Forecast in 2033
|
USD 6.5 Billion |
Market Growth Rate 2025-2033 | 5.88% |
An intraoperative neuromonitoring (IONM) system comprises a group of procedures that can detect, monitor, and confirm nerve function and help minimize the odds of neurological problems during or after neurological surgical procedures. It reduces the risks of nerve function being damaged as a result of improper positioning of the patient or any neurophysiologically-relevant nerve structures. An IONM allows surgeons to identify electrophysiologic changes during spine, head or neck surgery, which may be crucial in extending incisions, placing implants, positioning limbs, and performing retraction techniques that can prevent permanent nerve damage. Using targeted neurostimulation, nerve structures can be identified to prevent potential damage, thus allowing surgeons to focus on optimizing interventions while preserving function. Consequently, these systems are extensively used in neuro, ENT, emergency, visceral, cardiothoracic, orthopedic, and vascular surgeries.
The market is majorly driven by the augmenting focus on patient safety during complex surgical procedures. This can be attributed to a considerable rise in the prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson’s disease and Alzheimer’s disease. In addition to this, the escalating demand for minimally invasive and non-invasive surgeries resulting in a higher uptake of advanced intraoperative neuromonitoring devices is propelling the market. Moreover, the growing trend of medical tourism across the globe is also creating lucrative growth opportunities for the market. The market is further driven by the expanding expenditure on advanced healthcare services. Some of the other factors providing an impetus to the market include the paradigm shift towards outsourced monitoring, the increasing geriatric population that is susceptible to developing neurological disorders, favorable government initiatives and reimbursement plans, and extensive research and development (R&D), collaborations, and joint ventures among the key players.
IMARC Group provides an analysis of the key trends in each sub-segment of the global intraoperative neuromonitoring (IONM) market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product and services, source type, application and end user.
Breakup by Product and Services:
Breakup by Source Type:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The report has also provided a comprehensive analysis of the competitive landscape in the global intraoperative neuromonitoring (IONM) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product and Services, Source Type, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc. and Technomed |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global Intraoperative Neuromonitoring (IONM) market was valued at USD 3.8 Billion in 2024.
We expect the global Intraoperative Neuromonitoring (IONM) market to exhibit a CAGR of 5.88% during 2025-2033.
The growing need for patient safety during complex surgical procedures, along with the rising prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson’s disease, etc., is primarily driving the global Intraoperative Neuromonitoring (IONM) market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cardiothoracic, orthopedic, and vascular surgeries to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for Intraoperative Neuromonitoring (IONM).
Based on the source type, the global Intraoperative Neuromonitoring (IONM) market has been divided into insourced monitoring and outsourced monitoring. Currently, insourced monitoring exhibits a clear dominance in the market.
Based on the application, the global Intraoperative Neuromonitoring (IONM) market can be categorized into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and others. Among these, neurosurgery holds the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global Intraoperative Neuromonitoring (IONM) market include Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc., and Technomed.